Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis

doi:10.12998/wjcc.v10.i3.966

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4636)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

276

WORD

HTML

1908

Figures (1-4)

285

Tables (1-5)

293

Sum=2851

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

443

Download

1342

Sum=1785

Jan 21, 2022 (publication date) through Jan 2, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Jan 21, 2022; 10(3): 966-984
Published online Jan 21, 2022. doi: 10.12998/wjcc.v10.i3.966

Table 5 Societal recommendations for colorectal cancer surveillance in inflammatory bowel disease patients with post-inflammatory polyps

Society	Surveillance intervals	Surveillance techniques
AGA 2010	More frequent surveillance (No specific interval recommended)	Chromoendoscopy with targeted biopsies OR Standard or high-definition colonoscopy along with random biopsies
ASGE 2015	Every year	Chromoendoscopy with targeted biopsies OR Random biopsies (2-4 biopsies every from 10 cm) and targeted biopsies if chromoendoscopy is not available or the yield of chromoendoscopy is reduced
Cancer Council Australian 2019	Every year	Chromoendoscopy with targeted biopsies
BSG/ACPGBI 2010	Every 3 yr	Chromoendoscopy with targeted biopsies OR Random biopsies (2-4 biopsies every from 10 cm) and targeted biopsies if chromoendoscopy is not available
NICE 2011	Every 3 yr	Chromoendoscopy with targeted biopsies
ECCO 2013/2017	Every 2-3 yr	Chromoendoscopy with targeted biopsies OR White light endoscopy with random biopsies (4 biopsies every from 10 cm) and targeted biopsies
JSGE 2018/2020	Not mention the definite interval (Every 1-2 yr for patients with left-sided colitis or extensive colitis)	Chromoendoscopy with targeted biopsies OR Available endoscopic technology with targeted biopsies to increase the neoplasia detection rate
Chinese Society of Gastroenterology 2018/2020	Not mention the definite interval (Every 1-2 yr for patients with left-sided colitis or extensive colitis)	Chromoendoscopy/magnifying endoscopy with targeted biopsies

IBD: Inflammatory bowel disease; PIPs: Post-inflammatory polyps; AGA: American Gastroenterology Association; ASGE: American Society of Gastrointestinal Endoscopy; BSG: The British Society of Gastroenterology; ACPGBI: The Association of Coloproctology for Great Britain and Ireland; NICE: National Institute for Clinical Excellence; ECCO: The European Crohn’s and Colitis Organization; JSGE: The Japanese Society of Gastroenterology.

Citation: Shi JL, Lv YH, Huang J, Huang X, Liu Y. Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis. World J Clin Cases 2022; 10(3): 966-984
URL: https://www.wjgnet.com/2307-8960/full/v10/i3/966.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i3.966